Yoshihiro Kikuchi

Tochigi, 3248501, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: a retrospective analysis.

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: a retrospective analysis.

Journal: BMC cancer

Published: September 27, 2021

The analysis of Period1 gene expression in vivo and in vitro using a micro PMT system.

The analysis of Period1 gene expression in vivo and in vitro using a micro PMT system.

Journal: Biochemical and biophysical research communications

Published: August 06, 2021

Double recording system of Period1 gene expression rhythm in the olfactory bulb and liver in freely moving mouse.

Double recording system of Period1 gene expression rhythm in the olfactory bulb and liver in freely moving mouse.

Journal: Biochemical and biophysical research communications

Published: May 05, 2020

Mouse period1 gene expression recording from olfactory bulb under free moving conditions with a portable optic fibre device.

Mouse period1 gene expression recording from olfactory bulb under free moving conditions with a portable optic fibre device.

Journal: Luminescence : the journal of biological and chemical luminescence

Published: February 03, 2020

Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.

Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer.

Journal: BMC cancer

Published: January 14, 2019

Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin: Case Report and Review of the Literature.

Liver Metastasis of a Triple-Negative Breast Cancer and Complete Remission for 5 Years After Treatment With Combined Bevacizumab/Paclitaxel/Carboplatin: Case Report and Review of the Literature.

Journal: Medicine

Published: October 27, 2015

Understanding Ligand-Exchange Reactions on Thiolate-Protected Gold Clusters by Probing Isomer Distributions Using Reversed-Phase High-Performance Liquid Chromatography.

Understanding Ligand-Exchange Reactions on Thiolate-Protected Gold Clusters by Probing Isomer Distributions Using Reversed-Phase High-Performance Liquid Chromatography.

Journal: ACS nano

Published: July 14, 2015

Expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancer.

Expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancer.

Journal: Human cell

Published: January 17, 2014

UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama Tumor Board study.

UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama Tumor Board study.

Journal: European journal of gynaecological oncology

Published: June 21, 2013

Complete remission of recurrent and refractory ovarian cancers using weekly administration of bevacizumab and gemcitabine/oxaliplatin: report of two cases.

Complete remission of recurrent and refractory ovarian cancers using weekly administration of bevacizumab and gemcitabine/oxaliplatin: report of two cases.

Journal: European journal of gynaecological oncology

Published: April 18, 2013

A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted Therapies.

A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted Therapies.

Journal: International journal of molecular sciences

Published: February 17, 2013

Weekly administration of bevacizumab, gemcitabine, and oxaliplatin in patients with recurrent and refractory ovarian cancer: a preliminary result of 19 cases.

Weekly administration of bevacizumab, gemcitabine, and oxaliplatin in patients with recurrent and refractory ovarian cancer: a preliminary result of 19 cases.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: January 30, 2013

Showing 1-12 of 53

Last Updated: 09/26/2026